Global Monoclonal Antibodies Market Assessment, By Production Methods [In Vivo, In Vitro], By Indication [Disease Treatment, Diagnosis, Research], By Source [Chimeric, Human, Murine, Humanized, Others], By Route of Administration [Oral, Intravenous, Subcutaneous, Intramuscular, Intravitreal, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others], By End-users [Hospitals, Specialty Clinics, Homecare, Others], By Region, Opportunities and Forecast, 2017-2031F

Global monoclonal antibodies market size was valued at USD 216.4 billion in 2023, which is expected to reach USD 554.84 billion in 2031, with a CAGR of 12.49% for the forecast period between 2024 and 2031F.

Monoclonal Antibodies Market Size & Share Report, 2031

Global Monoclonal Antibodies Market Assessment, Opportunities and Forecast, 2017-2031F

Global monoclonal antibodies market is rising in pursuit of the prevalence of chronic ailments perpetuating the demand for precise and personalized treatments, where monoclonal antibodies illustrate a significant potential.

FAQs

Industry Reports

Blogs

Case Studies

Industry News

Press Release

Infographics